The global ophthalmic devices market size is estimated to reach USD 29.80 billion by 2030, expanding at a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population is presumed to propel the need for ophthalmic devices due to the high risk of developing chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population will be about 72 million individuals by 2030. The rising prevalence of eye disorders, such as macular degeneration, cataracts, diabetic retinopathy, and glaucoma, is also boosting product demand. As per the WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed the "Silent Thief of Sight," which is the second-leading cause of blindness.
The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population's screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.
Request a free sample copy or view report summary: Ophthalmic Devices Market Report
Based on product, The optical coherence tomography (OCT) segment dominated the market and accounted for the largest revenue share of 23.3% in 2024.
The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
The ophthalmoscopes segment is anticipated to witness a significant growth rate of 8.1% over the forecast period.
The cataract segment dominated the market and accounted for the largest revenue share of 41.5% in 2024.
This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries
Grand View Research has segmented the global ophthalmic devices market based on product, application, end use, and region:
Ophthalmic Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Optical Coherence Tomography Scanners
Fundus Camera
Perimeters/Visual Field Analyzers
Autorefractors and Keratometers
Ophthalmic Ultrasound Imaging Systems
Ophthalmic A-Scan Ultrasound
Ophthalmic B-Scan Ultrasound
Ophthalmic Ultrasound Biomicroscopes
Ophthalmic Pachymeters
Tonometers
Slit Lamps
Phoropters
Wavefront Aberrometers
Optical Biometry Systems
Ophthalmoscopes
Lensmeters
Corneal Topography Systems
Specular Microscopes
Retinoscopes
Ophthalmic Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Cataract
Vitreo Retinal Disorders
Glaucoma
Refractor Disorders
Ophthalmic Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals and Eye Clinics
Academic and Research Laboratories
Others
Ophthalmic Devices Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Ophthalmic Devices Market
Johnson & Johnson Vision Care
Alcon Vision LLC
Carl Zeiss Meditec AG
Bausch & Lomb Incorporated
Essilor International S.A
Ziemer Ophthalmic Systems Ltd
Nidek Co. Ltd
TOPCON Corporation
Haag-Streit Group
Glaukos Corporation
"The quality of research they have done for us has been excellent..."